Stimulants are one of the most widely prescribed classes of pharmaceuticals, but it is unclear which 28 brain pathways underlie their therapeutic and adverse actions. Here, with real-time monitoring of circuit 29 plasticity, we demonstrate that psychostimulants strengthen orbitofrontal (OFC) to dorsomedial striatum 30 (DMS) pathway synapses, and increase striatal output in awake mice. In vivo high-frequency stimulation of 31 OFC-DMS pathway blocked stimulant-induced potentiation and the expression of locomotor sensitization, 32 thereby directly linking OFC-DMS plasticity to hyperactivity.
effects of psychostimulants.
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To determine which striatal subdivisions were most activated by psychostimulants, we analysed 27 , p = 0.0003; drug main effect: F(1,14) = 17.13, p = 0.0010; subregion Χ drug interaction: F(2,28) = 13.63, p < 0.0001; followed by Bonferroni post-hoc test, DLS vs DMS: t(7) = 4.433; DMS vs VS: t(7) = 3.909). OFCe LFP amplitude upon d-SAL or d-amph injection (two-way ANOVA; time main effect: F(1,626) = 21.20, p < 0.0001; drug main effect: F(1,626) = 54.76, p < 0.0001; time Χ drug interaction: F(1,626) = 54.76, p < 0.0001, followed by Bonferroni post-hoc test dSAL vs d-Amph; 1-30: t(626) = 0, p > 0.9999; 31-60: t(626) = 10.47). (e) Pie-charts with numbers of non-significantly modulated, potentiated or depressed OFCe LFP responses. (f) Time-course of norm. velocity upon GBR13069 or saline i.p. injection (RM two-way ANOVA; time main effect: F(4.840,77.44) = 3.588, p = 0.0062; drug main effect: F(1,16) = 9.044, p = 0.0084; time Χ drug interaction: F(119,1904) = 4.656, p < 0.0001). (g) Time-course of normalized OFCe LFP responses upon saline or GBR13069 i.p. injection (RM two-way ANOVA; time main effect: F(119,56280) = 13.83, p < 0.0001; drug main effect: F(1,56280) = 415.1, p < 0.0001; time Χ drug interaction: F(119,56280) = 16.61, p < 0.0001). (h) Binned OFCe LFP amplitude upon saline or GBR13069 i.p. injection (two-way ANOVA; time main effect: F(1,938) = 12.42, p = 0.0004; drug main effect: F(1,938) = 50.17, p < 0.0001; time Χ drug interaction: F(1,938) = 50.17, p < 0.0001; followed by Bonferroni post-hoc test gSAL vs GBR13; 1-30: t(938) = 0, p> 0.9999; 31-60: t(938) = 10.02). (i) Pie-charts reporting the number of non-modulated, potentiated or depressed OFCe LFP responses. (j) Raster plot of % change in OFCe LFP responses upon application of cocaine, d-Amph and GBR13069 relative to their respective controls (one-way ANOVA, F(2,712) = 12.76, p < 0.0001, followed by one-sided t-test to 100%, cocaine: t(311) = 9.469; d-amph: t(164) = 6.421, GBR13: t(237) = 6.120). = 20.37, p = 0.0028; time Χ drug interaction: F(59,413) = 2.891, p < 0.0001). (i) Binned norm. frequency of direct pathway calcium events (RM two-way ANOVA by both factors; time main effect: F(1,7) = 0.9040, p = 0.3734; drug main effect: F(1,7) = 53.77, p = 0.0002, time Χ drug interaction: F(1,7) = 72.32, p < 0.0001, followed by Bonferroni post-hoc test Saline vs Cocaine; 11-30: t(7) = 1.539, p = 0.3354; 31-60: t(7) = 8.137). (j) Norm. frequency of indirect pathway calcium events (RM two-way ANOVA by both factors; time main effect: F(59,295) = 1.118, p = 0.2729; drug main effect: F(1,5) = 21.45, p = 0.0057; time Χ drug interaction: F(59,295) = 2.5, p < 0.0001). (k) Binned frequency of indirect pathway calcium events (RM two-way ANOVA by both factors; time main effect: F(1,5) = 9.215, p = 0.0289; drug main effect: F(1,5) = 13.48, p = 0.0144; time Χ drug interaction: F(1,5) = 25.37, p = 0.0040; followed by Bonferroni post-hoc test Saline vs Cocaine; 11-30: t(5) = 0.9309, p = 0.7893; 31-60: t(5) = 4.583). Data are represented as single points and/or as mean ± SEM. N indicates number of multi-units or animals included in the analysis.
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in the DMS to record calcium bulk signal from each pathway in this region (Figure 2g ). D1Cre and A2aCre pathways (Figure 2j,k) . Our data indicate that the cocaine-induced potentiation of OFC-striatal synaptic 108 efficacy is accompanied by activation of both striatal output pathways. 
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Anesthesia was induced with isoflurane at 2-3% and maintained during the entire surgery with isoflurane 361 at 0.5-1.5%, delivered via a mouse mask mounted on a stereotaxic apparatus (Stoelting). Ear bars and 362 mouth holder were used to keep the mouse head in place while the skin was shaved and disinfected with 363 a povidone/iodine solution. The skull was exposed and a hole of approximately 0.5-1 mm diameter was 364 performed with a microdrill. A 5 μL Hamilton syringe was connected to a 33gauge steel injector (Plastics1) 365 via a hydraulic system. The injector was pre-loaded with AAVs and gently lowered into the brain at the 366 following coordinates: OFC: AP + 2.5 mm, ML +1.1 mm, DV -2.5 mm; DMS: AP +0.5 mm, ML +1.5 mm, DV
367
-2.8 mm (from bregma). A total volume of 500 nl of viral solution was delivered at each infection site with a 368 syringe pump (Harvard apparatus) at a rate of 50 nL/min. The injector was left in place for 5 minutes after 369 the infusion.
370
For in vivo electrophysiology experiments, the animals received a unilateral infection of the OFC. After 371 removal of injector, suture (Coated VICRYL, polyglactin 910; Ethicon) followed by povidone/iodine were 372 applied to close the wound. Animals were placed back in their home-cages on a pre-heated pad at 37°C 373 until complete recovery and subcutaneously injected with buprenorphine (0.05 mg/kg). Animals were 374 allowed at least 2 weeks for viral expression before electrodes were implanted in a second surgery.
375
For fiber photometry experiments, immediately after unilateral viral infusion in DMS, a 5 mm long fiber optic 376 cannulae (200 μm, 0.39 NA, 1.25 mm) with stainless steel ferrule (Thorlabs) was gently lowered into DMS 377 between 0.5-0.3 mm above the infusion site for GCamP6s-emitted fluorescence recordings.
378
For behavioral experiments with cocaine and OFC-DMS input stimulation, mice received bilateral opsin 379 viral infusions in the OFC. In the same surgery, two fiber optic cannulae (200 μm, 0.39 NA, 1.25 mm, the implant was fortified with acrylic dental cement. Upon solidification of the implant, animals were placed
In vivo electrophysiology recordings the beginning of OFC illumination (ON period). A paired t-test between trial-by-trial values of firing frequency
